The Use of Botulinum Toxin in the Management of Myofascial Pain Syndrome
NCT06824324
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
14
Enrollment
OTHER
Sponsor class
Conditions
Myofacial Pain Syndrome
Interventions
DRUG:
intramuscular Botulinum Toxin
Sponsor
Yassir R. Al-khannaq